PlainMeds provides educational information only. This is not medical advice. Always consult your doctor or pharmacist.

bictegravir/emtricitabine/tenofovir vs gentamicin

Side-by-side comparison of bictegravir/emtricitabine/tenofovir and gentamicin. Data from FDA drug databases (Orange Book, NDC Directory, recalls, shortages) covering 20,000+ approved drugs, plus CMS pricing; see our methodology.

minor Known Drug Interaction

Some examples of drugs that are eliminated by active tubular secretion include, but are not limited to, acyclovir, cidofovir, ganciclovir, valacyclovir, valganciclovir, aminoglycosides (e.g., gentamicin), and high-dose or multiple NSAIDs [see Warnings and Precautions (5.4) ] .

Recommendation: Your doctor should monitor your kidney function closely while you are taking these medicines together.

Drug Class
bictegravir/emtricitabine/tenofovir Integrase Inhibitor / NRTI Combination
gentamicin Aminoglycoside Antibiotic
Type
bictegravir/emtricitabine/tenofovir Prescription
gentamicin Prescription
Summary
bictegravir/emtricitabine/tenofovir

Biktarvy is a complete HIV-1 treatment for adults and children who weigh at least 31 pounds. It combines three medicines into one tablet to help control the virus.

gentamicin

Gentamicin is an antibiotic medicine. It fights serious infections caused by certain bacteria.

What It Treats
bictegravir/emtricitabine/tenofovir

Biktarvy treats Human Immunodeficiency Virus type 1 (HIV-1) in adults and children weighing at least 31 pounds. It can be used if you have never taken HIV medicine before. It can also replace your current HIV medicine if your virus is under control and you have no resistance to Biktarvy's components.

gentamicin

Gentamicin treats serious infections caused by certain bacteria. This includes infections in the blood, brain (meningitis), urinary tract, lungs, stomach area, skin, bone, and soft tissues. It can also treat bacterial infections in newborns.

How It Works
bictegravir/emtricitabine/tenofovir

Biktarvy contains three drugs that each block HIV in different ways. Bictegravir stops HIV from inserting its DNA into your cells. Emtricitabine and tenofovir alafenamide interfere with an enzyme HIV needs to make copies of itself.

gentamicin

Gentamicin belongs to a class of drugs called aminoglycoside antibiotics. It works by stopping the growth of bacteria. This helps your body fight off the infection.

Common Side Effects
bictegravir/emtricitabine/tenofovir
  • Diarrhea
  • Nausea
  • Headache
gentamicin

No common side effects listed.

FAERS Reports
bictegravir/emtricitabine/tenofovir

No adverse event reports.

gentamicin
  • Acute Kidney Injury 999
  • Pyrexia 751
  • Renal Failure 603
  • Diarrhoea 460
  • Sepsis 427
Serious Warnings
bictegravir/emtricitabine/tenofovir

If you have both HIV and hepatitis B, stopping Biktarvy can cause your hepatitis B to suddenly get worse. Your doctor will need to monitor your liver closely for several months after you stop taking Biktarvy. You may need to take medicine for hepatitis B.

gentamicin

Gentamicin can potentially damage kidneys and cause nerve damage, including hearing loss. The risk is higher if you have kidney problems, receive high doses, or take it for a long time. Tell your doctor right away if you notice dizziness, ringing in your ears, changes in hearing, or kidney problems.

Pregnancy
bictegravir/emtricitabine/tenofovir

There is a pregnancy registry to track outcomes in women who take Biktarvy during pregnancy. Talk to your doctor about the risks and benefits of taking Biktarvy if you are pregnant or planning to become pregnant. There is not enough data to assess the risk of major birth defects.

gentamicin

Tell your doctor if you are pregnant or breastfeeding. Gentamicin may harm your unborn baby. It is not known if gentamicin passes into breast milk.

Also Compare, Nearby Drugs

How to Read This bictegravir/emtricitabine/tenofovir vs gentamicin Comparison

bictegravir/emtricitabine/tenofovir is classified in the Integrase Inhibitor / NRTI Combination drug class, while gentamicin sits within the Aminoglycoside Antibiotic class. Drugs from different classes work through distinct mechanisms, so a head-to-head comparison illustrates trade-offs rather than equivalence. Both drugs are prescription-only, so a licensed provider must authorize use.

Adverse event totals above are pulled from the FDA's Adverse Event Reporting System (FAERS). For these top-ranked reactions alone, bictegravir/emtricitabine/tenofovir has 0 submissions while gentamicin has 3,240. Those figures reflect cumulative reporting volume, not per-patient risk, so older, widely dispensed drugs typically look worse on count alone. These two drugs have a known minor interaction flagged in FDA labeling, attributed to both drugs are removed from the body through the same pathway in the kidneys. taking them together may cause the drugs to build up in your system.. Serious warnings, pregnancy guidance, and contraindications can differ even when indications overlap.

A table cannot substitute for clinical judgment. Effectiveness, tolerability, drug-drug interactions with your other medications, kidney and liver function, pregnancy status, insurance formulary, and price all feed into a decision that only a licensed prescriber can make responsibly. Data here is sourced from FDA Structured Product Labels (SPL) and FAERS, both of which update as manufacturers and clinicians submit new information. This page is for educational purposes only, is not medical advice, and should not be used to self-switch between bictegravir/emtricitabine/tenofovir and gentamicin - always consult your physician or pharmacist first.

Important: This comparison is for informational purposes only. Drug effects vary between individuals. Always consult your doctor or pharmacist for personalized medical advice.